Detalhe da pesquisa
1.
SARS-CoV-2 uses CD4 to infect T helper lymphocytes.
Elife
; 122023 07 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37523305
2.
Plasma Angiotensin II Is Increased in Critical Coronavirus Disease 2019.
Front Cardiovasc Med
; 9: 847809, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35811697
3.
Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin-Kallikrein System in Severe COVID-19.
Viruses
; 13(2)2021 02 16.
Artigo
Inglês
| MEDLINE | ID: mdl-33669276
4.
Rapid clinical recovery of a SARS-CoV-2 infected common variable immunodeficiency patient following the infusion of COVID-19 convalescent plasma.
Allergy Asthma Clin Immunol
; 17(1): 14, 2021 Feb 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33546745
5.
Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial.
Trials
; 22(1): 71, 2021 Jan 20.
Artigo
Inglês
| MEDLINE | ID: mdl-33472675
6.
Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis.
Cell Metab
; 32(3): 437-446.e5, 2020 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32697943
7.
Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis.
Cell Metab
; 32(3): 498-499, 2020 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32877692